These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 23108123)

  • 21. Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients.
    Sandroussi C; Crawford M; Lockwood DS; Tang P; Gallagher JP; Pleass H; Strasser SI; Shackel NA; McCaughan GW; Verran DJ
    Liver Transpl; 2009 Nov; 15(11):1586-93. PubMed ID: 19877214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living donor liver transplantation in children: should the adult donor be operated on by an adult or pediatric surgeon? Experience of a single pediatric center.
    Andrade Wde C; Velhote MC; Ayoub AA; Silva MM; Gibelli NE; Tannuri AC; Santos MM; Pinho-Apezzato ML; de Barros F; Moreira DR; Miyatani HT; Pereira RR; Tannuri U
    J Pediatr Surg; 2014 Apr; 49(4):525-7. PubMed ID: 24726105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of recipient pretransplant MELD-AS score and graft size on the outcome of adult-to-adult living donor liver transplantation].
    Feng X; Wei YG; Li FQ; Yuan D; Jiang H; Du ZG; Yin J; Li B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):801-4. PubMed ID: 19024318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.
    Duan BW; Lu SC; Wang ML; Liu JN; Chi P; Lai W; Wu JS; Guo QL; Lin DD; Liu Y; Zeng DB; Li CY; Meng QH; Ding HG; Chen XY; Liao HY; Ma LQ; Chen Y; Zhang J; Xiang HP; Duan ZP; Li N
    J Surg Res; 2013 Aug; 183(2):936-43. PubMed ID: 23558257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study of adult to adult living donor liver transplantation: a report of 56 cases].
    Yan LN; Li B; Zeng Y; Wen TF; Wang WT; Yang JY; Xu MQ; Chen ZY; Zhao JC; Ma YK; Wu H
    Zhonghua Wai Ke Za Zhi; 2007 Mar; 45(5):304-8. PubMed ID: 17535706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival Outcomes in Split Compared With Whole Liver Transplantation.
    Chul Yoon K; Song S; Jwa EK; Lee S; Man Kim J; Kim OK; Kyun Hong S; Yi NJ; Lee KW; Soo Kim M; Hwang S; Suh KS; Lee SK
    Liver Transpl; 2018 Oct; 24(10):1411-1424. PubMed ID: 29747216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right lobe living donors ages 55 years old and older in liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor age does not influence 12-month outcome after orthotopic liver transplantation.
    Faber W; Seehofer D; Puhl G; Guckelberger O; Bertram C; Neuhaus P; Bahra M
    Transplant Proc; 2011 Dec; 43(10):3789-95. PubMed ID: 22172848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application?
    Decoster EL; Troisi R; Sainz-Barriga M; Haentjens I; Colenbie L; Geerts A; Colle I; Van Vlierberghe H; de Hemptinne B; Rogiers X
    Transplant Proc; 2009 Oct; 41(8):3485-8. PubMed ID: 19857777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher retransplantation rate following extended right split-liver transplantation: An analysis from the eurotransplant liver follow-up registry.
    Andrassy J; Wolf S; Lauseker M; Angele M; van Rosmalen MD; Samuel U; Rogiers X; Werner J; Guba M;
    Liver Transpl; 2018 Jan; 24(1):26-34. PubMed ID: 29144580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Living donor liver transplantation with dual grafts -- a case report.
    Botea F; Braşoveanu V; Constantinescu A; Ionescu M; Matei E; Popescu I
    Chirurgia (Bucur); 2013; 108(4):547-52. PubMed ID: 23958100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors of SFSS in adult-to-adult living donor liver transplantation using the right liver: a single-center analysis of 217 cases.
    Lei JY; Wang WT; Yan LN
    Hepatogastroenterology; 2012; 59(117):1491-7. PubMed ID: 22094994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of in-situ full-left/full-right split liver transplantation for adult recipients using the living donor liver transplantation technique:a single-center report of 25 cases].
    Wu SD; Huang J; Fang JZ; Lu CJ; Wang GQ; Wang K; Ye S; Jiang W; Zhu HD; Hu YK; Mao SQ; Lu CD
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):906-914. PubMed ID: 36207979
    [No Abstract]   [Full Text] [Related]  

  • 38. Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation.
    Alim A; Erdogan Y; Yuzer Y; Tokat Y; Oezcelik A
    Liver Transpl; 2016 Dec; 22(12):1643-1648. PubMed ID: 27509534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.